Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancer. (Q54484686)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancer. |
scientific article |
Statements
Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancer. (English)
Vassiliki A Papadimitrakopoulou
Jean-Charles Soria
Annette Jappe
Valentine Jehl
Judith Klimovsky
Bruce E Johnson
1 October 2012
7
10
1594-1601